|Articles|October 1, 1997

October 1997
Volume 3
Issue 10

Evolving Therapy for Helicobacter pylori Infection: Efficacy and Economic Impact in the Treatment of Patients with Duodenal Ulcer Disease

Author(s)Alan F. Cutler, MD, Nimish Vakil, MD

Download PDF: Evolving Therapy for Helicobacter pylori Infection: Efficacy and Economic Impact in the Treatment of Patients with Duodenal Ulcer Disease

Articles in this issue

over 28 years ago

Article

The Abilities of Primary Care Physicians in Dermatology: Implications for Quality of Care

over 28 years ago

Article

Physicians' Views on Capitated Payment for Medical Care: Does Familiarity Foster Acceptance?

over 28 years ago

Article

Using Evidence-Based Techniques to Modify Anemia Screening Practice

over 28 years ago

Article

Migraine: A Problem for Employers and Managed Care Plans

over 28 years ago

Article

Postmarketing Analysis of Lovastatin Use in the VA Northern California System of Clinics: A Retrospective, Computer-Based Study

over 28 years ago

Article

Antiviral Therapy for Neonatal Herpes Simplex Virus: A Cost-Effectiveness Analysis

over 28 years ago

Article

Differences in Costs of Treatment for Foot Problems between Podiatrists and Orthopedic Surgeons

over 28 years ago

Article

Travel Medicine: Considerations for the Primary Care Physician

over 28 years ago

Article

Diabetes Management: Current Diagnostic Criteria, Drug Therapies, and State Legislation

over 28 years ago

Article

Correspondence regarding, "The Diagnosis and Treatment Approach to Two Common Conditions by the Physician Members of a Community Health Plan"

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Evolving Therapy for Helicobacter pylori Infection: Efficacy and Economic Impact in the Treatment of Patients with Duodenal Ulcer Disease

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD